CN100341489C - 一种具有补肾壮骨作用的仙灵骨葆滴丸及其制备方法 - Google Patents
一种具有补肾壮骨作用的仙灵骨葆滴丸及其制备方法 Download PDFInfo
- Publication number
- CN100341489C CN100341489C CNB2005100806517A CN200510080651A CN100341489C CN 100341489 C CN100341489 C CN 100341489C CN B2005100806517 A CNB2005100806517 A CN B2005100806517A CN 200510080651 A CN200510080651 A CN 200510080651A CN 100341489 C CN100341489 C CN 100341489C
- Authority
- CN
- China
- Prior art keywords
- polyethylene glycol
- substrate
- mixed
- drop pill
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000006187 pill Substances 0.000 title claims abstract description 44
- 238000000034 method Methods 0.000 title abstract description 23
- 210000000988 bone and bone Anatomy 0.000 title abstract description 9
- 210000003734 kidney Anatomy 0.000 title abstract description 7
- 238000005728 strengthening Methods 0.000 title description 6
- 230000003014 reinforcing effect Effects 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 90
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 230000007812 deficiency Effects 0.000 claims abstract description 8
- 208000001132 Osteoporosis Diseases 0.000 claims abstract description 7
- 239000008280 blood Substances 0.000 claims abstract description 7
- 210000004369 blood Anatomy 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 83
- 239000002202 Polyethylene glycol Substances 0.000 claims description 82
- 239000000758 substrate Substances 0.000 claims description 43
- -1 polyoxyethylene stearate Polymers 0.000 claims description 36
- 150000002148 esters Chemical class 0.000 claims description 28
- 229920002472 Starch Polymers 0.000 claims description 25
- 235000019698 starch Nutrition 0.000 claims description 25
- 239000008107 starch Substances 0.000 claims description 25
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 22
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 22
- 239000011734 sodium Substances 0.000 claims description 22
- 229910052708 sodium Inorganic materials 0.000 claims description 22
- 239000000796 flavoring agent Substances 0.000 claims description 15
- 235000019634 flavors Nutrition 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 6
- 210000004185 liver Anatomy 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 238000007598 dipping method Methods 0.000 claims description 2
- 238000005470 impregnation Methods 0.000 claims description 2
- 229940057995 liquid paraffin Drugs 0.000 claims description 2
- 238000000465 moulding Methods 0.000 claims description 2
- 229920002545 silicone oil Polymers 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 99
- 238000002360 preparation method Methods 0.000 abstract description 30
- 230000000694 effects Effects 0.000 abstract description 11
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 239000000470 constituent Substances 0.000 abstract description 2
- 238000004321 preservation Methods 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 2
- 241001559589 Cullen Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 206010015866 Extravasation Diseases 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 230000036251 extravasation Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 230000002787 reinforcement Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 82
- 239000011159 matrix material Substances 0.000 description 58
- 229940023488 pill Drugs 0.000 description 35
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 27
- 229920001983 poloxamer Polymers 0.000 description 27
- 229960000502 poloxamer Drugs 0.000 description 27
- 238000002474 experimental method Methods 0.000 description 21
- 229920000858 Cyclodextrin Polymers 0.000 description 19
- 239000001116 FEMA 4028 Substances 0.000 description 19
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 19
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 19
- 229960004853 betadex Drugs 0.000 description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- 239000008194 pharmaceutical composition Substances 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 12
- 239000000969 carrier Substances 0.000 description 9
- 239000001828 Gelatine Substances 0.000 description 8
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 8
- 239000004141 Sodium laurylsulphate Substances 0.000 description 8
- 235000021355 Stearic acid Nutrition 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 229920000159 gelatin Polymers 0.000 description 8
- 235000019322 gelatine Nutrition 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 8
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 8
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 8
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 8
- 239000008117 stearic acid Substances 0.000 description 8
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 235000008216 herbs Nutrition 0.000 description 7
- 239000000428 dust Substances 0.000 description 4
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000010579 first pass effect Methods 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 235000015250 liver sausages Nutrition 0.000 description 2
- 239000007935 oral tablet Substances 0.000 description 2
- 229940096978 oral tablet Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 102000000340 Glucosyltransferases Human genes 0.000 description 1
- 108010055629 Glucosyltransferases Proteins 0.000 description 1
- 241001640034 Heteropterys Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 125000002791 glucosyl group Chemical class C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- FDRCDNZGSXJAFP-UHFFFAOYSA-M sodium chloroacetate Chemical compound [Na+].[O-]C(=O)CCl FDRCDNZGSXJAFP-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
基质名称 | 有效成分(%) | 圆整率(%) | 溶散时限(分钟) | 丸重差异(%) | 硬度 |
聚乙二醇1000 | 50.0 | 67 | <30 | >10 | + |
聚乙二醇4000 | 50.0 | 84 | <30 | >10 | + |
聚乙二醇6000 | 50.0 | 85 | <30 | >10 | + |
聚乙二醇10000 | 50.0 | 84 | <30 | >10 | ++ |
聚乙二醇20000 | 50.0 | 83 | <30 | >10 | ++ |
司盘40 | 50.0 | 63 | <30 | >10 | ++ |
硬脂酸聚烃氧40酯 | 50.0 | 75 | <30 | >10 | ++ |
泊洛沙姆 | 50.0 | 78 | <30 | >10 | ++ |
十二烷基硫酸钠 | 50.0 | 74 | >30 | >10 | ++ |
硬脂酸 | 50.0 | 60 | >30 | >10 | ++ |
硬脂酸钠 | 50.0 | 61 | >30 | >10 | ++ |
甘油明胶 | 50.0 | 60 | >30 | >10 | + |
虫胶 | 50.0 | 60 | >30 | >10 | + |
基质名称 | 有效成分(%) | 圆整率(%) | 溶散时限(分钟) | 丸重差异(%) | 硬度 |
聚乙二醇1000 | 25.0 | 71 | <30 | >10 | + |
聚乙二醇4000 | 25.0 | 86 | <30 | <10 | ++ |
聚乙二醇6000 | 25.0 | 88 | <30 | <10 | +++ |
聚乙二醇10000 | 25.0 | 88 | <30 | <10 | +++ |
聚乙二醇20000 | 25.0 | 87 | <30 | <10 | +++ |
司盘40 | 25.0 | 75 | <30 | >10 | +++ |
硬脂酸聚烃氧40酯 | 25.0 | 87 | <30 | <10 | ++ |
泊洛沙姆 | 25.0 | 89 | <30 | <10 | +++ |
十二烷基硫酸钠 | 25.0 | 73 | <30 | >10 | ++ |
硬脂酸 | 25.0 | 77 | >30 | >10 | +++ |
硬脂酸钠 | 25.0 | 73 | >30 | >10 | +++ |
甘油明胶 | 25.0 | 73 | >30 | >10 | +++ |
虫胶 | 25.0 | 73 | >30 | >10 | +++ |
基质名称 | 有效成分(%) | 圆整率(%) | 溶散时限(分钟) | 丸重差异(%) | 硬度 |
聚乙二醇1000 | 10.0 | 84 | <30 | >10 | + |
聚乙二醇4000 | 10.0 | 91 | <30 | <10 | ++ |
聚乙二醇6000 | 10.0 | 90 | <30 | <10 | +++ |
聚乙二醇10000 | 10.0 | 91 | <30 | <10 | +++ |
聚乙二醇20000 | 10.0 | 90 | <30 | <10 | +++ |
司盘40 | 10.0 | 73 | <30 | <10 | +++ |
硬脂酸聚烃氧40酯 | 10.0 | 87 | <30 | <10 | ++ |
泊洛沙姆 | 10.0 | 90 | <30 | <10 | +++ |
十二烷基硫酸钠 | 10.0 | 78 | <30 | >10 | +++ |
硬脂酸 | 10.0 | 77 | >30 | >10 | +++ |
硬脂酸钠 | 10.0 | 74 | >30 | >10 | +++ |
甘油明胶 | 10.0 | 73 | >30 | >10 | +++ |
虫胶 | 10.0 | 73 | >30 | >10 | +++ |
基质名称 | 有效成分(%) | 圆整率(%) | 溶散时限(分钟) | 丸重差异(%) | 硬度 |
硬脂酸聚烃氧40酯∶聚乙二醇=1∶1 | 50 | 83 | <30 | >10 | ++ |
泊洛沙姆∶聚乙二醇=1∶1 | 50 | 84 | <30 | >10 | ++ |
羧甲基淀粉钠∶聚乙二醇=1∶1 | 50 | 83 | <30 | >10 | ++ |
倍他环糊精∶聚乙二醇=1∶1 | 50 | 77 | <30 | >10 | + |
基质名称 | 有效成分(%) | 圆整率(%) | 溶散时限(分钟) | 丸重差异(%) | 硬度 |
硬脂酸聚烃氧40酯∶聚乙二醇=1∶1 | 25 | 90 | <30 | <10 | +++ |
泊洛沙姆∶聚乙二醇=1∶1 | 25 | 90 | <30 | <10 | +++ |
羧甲基淀粉钠∶聚乙二醇=1∶1 | 25 | 89 | <30 | <10 | +++ |
倍他环糊精∶聚乙二醇=1∶1 | 25 | 84 | <30 | >10 | ++ |
基质名称 | 有效成分(%) | 圆整率(%) | 溶散时限(分钟) | 丸重差异(%) | 硬度 |
硬脂酸聚烃氧40酯∶聚乙二醇=1∶1 | 10 | 91 | <30 | <10 | +++ |
泊洛沙姆∶聚乙二醇=1∶1 | 10 | 90 | <30 | <10 | +++ |
羧甲基淀粉钠∶聚乙二醇=1∶1 | 10 | 90 | <30 | <10 | +++ |
倍他环糊精∶聚乙二醇=1∶1 | 10 | 84 | <30 | >10 | +++ |
基质名称 | 有效成分(%) | 圆整率(%) | 溶散时限(分钟) | 丸重差异(%) | 硬度 |
硬脂酸聚烃氧40酯∶聚乙二醇=1∶5 | 50 | 91 | <30 | <10 | +++ |
泊洛沙姆∶聚乙二醇=1∶5 | 50 | 92 | <30 | <10 | +++ |
羧甲基淀粉钠∶聚乙二醇=1∶5 | 50 | 91 | <30 | <10 | +++ |
倍他环糊精∶聚乙二醇=1∶5 | 50 | 86 | <30 | <10 | ++ |
基质名称 | 有效成分(%) | 圆整率(%) | 溶散时限(分钟) | 丸重差异(%) | 硬度 |
硬脂酸聚烃氧40酯∶聚乙二醇=1∶5 | 25 | 92 | <30 | <10 | +++ |
泊洛沙姆∶聚乙二醇=1∶5 | 25 | 92 | <30 | <10 | +++ |
羧甲基淀粉钠∶聚乙二醇=1∶5 | 25 | 90 | <30 | <10 | +++ |
倍他环糊精∶聚乙二醇=1∶5 | 25 | 88 | <30 | <10 | +++ |
基质名称 | 有效成分(%) | 圆整率(%) | 溶散时限(分钟) | 丸重差异(%) | 硬度 |
硬脂酸聚烃氧40酯∶聚乙二醇=1∶5 | 10 | 92 | <30 | <10 | +++ |
泊洛沙姆∶聚乙二醇=1∶5 | 10 | 92 | <30 | <10 | +++ |
羧甲基淀粉钠∶聚乙二醇=1∶5 | 10 | 90 | <30 | <10 | +++ |
倍他环糊精∶聚乙二醇=1∶5 | 10 | 89 | <30 | <10 | +++ |
基质名称 | 有效成分(%) | 圆整率(%) | 溶散时限(分钟) | 丸重差异(%) | 硬度 |
硬脂酸聚烃氧40酯∶聚乙二醇=1∶10 | 50 | 92 | <30 | <10 | +++ |
泊洛沙姆∶聚乙二醇=1∶10 | 50 | 91 | <30 | <10 | +++ |
羧甲基淀粉钠∶聚乙二醇=1∶10 | 50 | 91 | <30 | <10 | +++ |
倍他环糊精∶聚乙二醇=1∶10 | 50 | 87 | <30 | >10 | +++ |
基质名称 | 有效成分(%) | 圆整率(%) | 溶散时限(分钟) | 丸重差异(%) | 硬度 |
硬脂酸聚烃氧40酯∶聚乙二醇=1∶10 | 25 | 92 | 0 | <10 | +++ |
泊洛沙姆∶聚乙二醇=1∶10 | 25 | 91 | <30 | <10 | +++ |
羧甲基淀粉钠∶聚乙二醇=1∶10 | 25 | 89 | <30 | <10 | +++ |
倍他环糊精∶聚乙二醇=1∶10 | 25 | 86 | <30 | <10 | +++ |
基质名称 | 有效成分(%) | 圆整率(%) | 溶散时限(分钟) | 丸重差异(%) | 硬度 |
硬脂酸聚烃氧40酯∶聚乙二醇=1∶10 | 10 | 92 | <30 | <10 | +++ |
泊洛沙姆∶聚乙二醇=1∶10 | 10 | 93 | <30 | <10 | +++ |
羧甲基淀粉钠∶聚乙二醇=1∶10 | 10 | 91 | <30 | <10 | +++ |
倍他环糊精∶聚乙二醇=1∶10 | 10 | 89 | <30 | <10 | +++ |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100806517A CN100341489C (zh) | 2005-07-06 | 2005-07-06 | 一种具有补肾壮骨作用的仙灵骨葆滴丸及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100806517A CN100341489C (zh) | 2005-07-06 | 2005-07-06 | 一种具有补肾壮骨作用的仙灵骨葆滴丸及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1723976A CN1723976A (zh) | 2006-01-25 |
CN100341489C true CN100341489C (zh) | 2007-10-10 |
Family
ID=35923693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100806517A Expired - Fee Related CN100341489C (zh) | 2005-07-06 | 2005-07-06 | 一种具有补肾壮骨作用的仙灵骨葆滴丸及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100341489C (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102343027B (zh) * | 2011-10-18 | 2013-01-23 | 贵州同济堂制药有限公司 | 一种仙灵骨葆提取物,含其制剂及其制备方法 |
CN103083521B (zh) * | 2013-02-20 | 2015-04-15 | 贵州同济堂制药有限公司 | 一种仙灵骨葆的提取方法、分离提取物及制剂 |
CN105998860A (zh) * | 2016-07-26 | 2016-10-12 | 钦州市中医医院 | 一种治疗骨关节病的中药组合物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1583133A (zh) * | 2004-06-03 | 2005-02-23 | 北京乾露春科技有限公司 | 一种治疗骨科疾病的泡腾片及其制备方法 |
-
2005
- 2005-07-06 CN CNB2005100806517A patent/CN100341489C/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1583133A (zh) * | 2004-06-03 | 2005-02-23 | 北京乾露春科技有限公司 | 一种治疗骨科疾病的泡腾片及其制备方法 |
Non-Patent Citations (2)
Title |
---|
国家药品监督管理局国家中成药标准汇编骨伤科分册 国家药品监,368-370,2002 * |
国家药品监督管理局国家中成药标准汇编骨伤科分册 国家药品监督管理局,368-370,2002 * |
Also Published As
Publication number | Publication date |
---|---|
CN1723976A (zh) | 2006-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1660368A (zh) | 一种用于清热解毒的口服滴丸及其制备方法 | |
CN1686439A (zh) | 一种用于化痰止咳的咳露滴丸及其制备方法 | |
CN100341489C (zh) | 一种具有补肾壮骨作用的仙灵骨葆滴丸及其制备方法 | |
CN1307980C (zh) | 一种治疗心血管疾病的乐脉滴丸及其制备方法 | |
CN1682923A (zh) | 一种用于补气提神的强身滴丸及其制备方法 | |
CN1682918A (zh) | 枣仁安神滴丸及其制备方法 | |
CN1686484A (zh) | 银菊清咽滴丸及其制备方法 | |
CN100341487C (zh) | 一种用于消炎的双黄消炎滴丸 | |
CN1682924A (zh) | 龟芪参滴丸及其制备方法 | |
CN1316961C (zh) | 罗汉果滴丸及其制备方法 | |
CN1316959C (zh) | 五加参归芪滴丸及其制备方法 | |
CN1292741C (zh) | 人参五味子滴丸及其制备方法 | |
CN100344314C (zh) | 一种用于补气养阴的滴丸及其制备方法 | |
CN1686339A (zh) | 复方锁阳滴丸及其制备方法 | |
CN1317010C (zh) | 一种用于强心益肾的滴丸及其制备方法 | |
CN1316962C (zh) | 咳喘安滴丸及其制备方法 | |
CN1686453A (zh) | 一种小儿咳喘滴丸及其制备方法 | |
CN1307983C (zh) | 一种治疗高脂蛋白血症的脉安滴丸及其制备方法 | |
CN1686340A (zh) | 一种滋补肝肾的天麻醒脑滴丸及其制备方法 | |
CN1682806A (zh) | 人参首乌滴丸及其制备方法 | |
CN1686477A (zh) | 银花芒果滴丸及其制备方法 | |
CN1682920A (zh) | 一种治疗神经衰弱的安神宁滴丸及其制备方法 | |
CN1686454A (zh) | 一种用于止咳化痰的消咳滴丸及其制备方法 | |
CN1682817A (zh) | 一种用于清热解毒的喉舒滴丸及其制备方法 | |
CN1292740C (zh) | 人参当归滴丸及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING ZHENGDA LVZHOU PHARMACY CO., LTD. Free format text: FORMER OWNER: ZHENGDA-LUZHOU MEDICINE SCIENCE-TECHNOLOGY CO., LTD., BEIJING Effective date: 20080516 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080516 Address after: Beijing City Industrial Development Zone Tongzhou District Guangyuan Street No. 1 Patentee after: Beijing Zhengda oasis Pharmaceutical Co.,Ltd. Address before: Beijing economic and Technological Development Zone Hongda North Road, 12 innovation building, block B, two, 201 Patentee before: Beijing Zhengda oasis Pharmaceutical Technology Co.,Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20151113 Address after: 336000 Yuanzhou pharmaceutical industry park, Jiangxi, Yichun Patentee after: JIANGXI JIMINKEXIN PHARMACEUTICAL Co.,Ltd. Address before: 101113 Beijing Guangyuan Industrial Development Zone in Tongzhou District Street No. 1 Patentee before: Beijing Zhengda oasis Pharmaceutical Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071010 |
|
CF01 | Termination of patent right due to non-payment of annual fee |